Description
Seeking men and woment 18 years of age or older who have been diagnosed with recurrent glioblastoma multiforme and who have failed standard first line therapy.
Overview
We are studying the investigational drug berubicin to determine how well it works compared to the standard therapy in treating recurrent glioblastoma multiforme.
What we're hoping for
Evaluate how safety, tolerable, and well, the investigational drug berubicin works compared to the standard therapy in treating recurrent glioblastoma multiforme.
Additional Information
ClinicalTrials.gov Identifier: NCT04762069